AIIMS director on Covid vaccine human trials, community spread: Key points
Monday, 20 July 2020 () The clinical trial of the indigenously developed Covid-19 vaccine candidate Covaxin will be conducted in three phases, AIIMS director Randeep Guleria told reporters on Monday. Guleria, addressing the media, also said that the transmission of the virus in the capital, barring certain areas, seems to have hit its peak.
Human trials of the coronavirus vaccine candidate being developed at the University of Oxford suggest it is safe and induces an immune response to Covid-19.Early results indicate the jab could provide double protection – generating an immune response which stimulates the body to produce both an...
The Union Health Ministry on August 04 briefed the media in Delhi, over the current COVID-19 situation in nation. Speaking in press conference, Ministry of Health, Secretary, Rajesh Bhushan stated that more than 6.6 lakh COVID-19 tests have been conducted in last 24 hours in the nation. Adding on it, he said recovered cases are now double of the active cases in India. He said, "More than 2 crore COVID-19 tests have been conducted, including more than 6.6 lakh tests in the last 24 hours. Recovered cases are now double of the active cases. The case fatality rate is lowest since the first lockdown."
Delhi Health Minister Satyendar Jain informed that Delhi has slipped on the table of COVID-19 active cases. "Earlier it was on second position and now it is on the fourteen position in terms of active cases," Satyendar Jain said. On serological survey, he said, "We will have to extend the serological survey in Delhi by 2 more days. Around 15,000 samples will be collected during the survey."
While addressing a press conference in the national capital on July 20, the director of All India Institute of Medical Sciences (AIIMS), Professor Randeep Guleria spoke on vaccine trail amid coronavirus pandemic. He said, "If you look at the data from Southeast Asia, not just India, the mortality rate is much lower than what happened in Italy and Spain or what is happening in the United States." "Certain areas have hit their peak. Delhi seems to have done so because the cases have declined significantly. Certain areas have yet to reach the peak. Cases are increasing in certain states. They will reach the peak a little later," AIIMS Director added.
While addressing a press conference in the national capital on July 20, the director of All India Institute of Medical Sciences (AIIMS), Professor Randeep Guleria spoke on vaccine trail amid coronavirus pandemic. He said, "There is not much evidence that there is community transmission happening at national level." "But there are hotspots, even in cities where there is spike of cases and it is very likely that local community transmission in those areas is happening," AIIMS Director added.
While addressing a press conference in the national capital on July 20, the director of All India Institute of Medical Sciences (AIIMS), Professor Randeep Guleria spoke on vaccine trail amid coronavirus pandemic. He said, "Phase 1 of vaccine trial will be done on healthy people aged between 18-55 years who have no co-morbidity." "A total of 1,125 samples have been collected of which 375 will be studied in first phase and in second phase 750 people will be recruited between 12-65 years," AIIMS Director added.
ACP of Delhi Traffic Police died on night of July 25 after a car hit him while he was managing traffic at Rajokri Flyover. Police rushed ACP to Kaushik to AIIMS hospital where he was declared dead by the doctors. The accused has not been identified yet. Police is investigating the matter.
All India Institute of Medical Sciences (AIIMS) in collaboration with Indian Institute of Technology (IIT) Jodhpur and Nagpur have developed a smart-wristband for COVID positive and suspected patients. The low-cost band helps in tracking and monitoring. "This band which helps in tracking and monitoring positive patients is valid in today's COVID-19 era. It will also help to track patients in quarantine," said AIIMS (Nagpur) director, Vibha Dutta.